Recombinant Human MAML2 Protein: Research Guide & Applications

Recombinant Human MAML2 Protein is a recombinantly expressed transcriptional coactivator that serves as an essential component of the Notch signaling pathway, enabling researchers to investigate gene regulation, oncogenic mechanisms, and protein–protein interactions in a controlled, reproducible in vitro setting.

Protein Name

Recombinant Human MAML2 (Mastermind-Like Protein 2)

SKU

rp369252

Biological Function

Transcriptional coactivator within the Notch signaling complex; interacts with the intracellular domain of Notch receptors and CSL/RBPJ transcription factors

Primary Research Applications

Notch pathway studies, transcription regulation assays, protein interaction studies, oncology research

Expression System

Recombinant expression system (specific host system: see product datasheet)

Storage Recommendation

Store at -80°C for long-term; avoid repeated freeze-thaw cycles (refer to product datasheet for confirmed conditions)

Biological Background of MAML2

MAML2 (Mastermind-Like Protein 2) is a member of the Mastermind-like (MAML) family of transcriptional coactivators, which also includes MAML1 and MAML3. These proteins are evolutionarily conserved and play critical roles in the canonical Notch signaling pathway. Upon Notch receptor activation, the intracellular domain of Notch (NICD) translocates to the nucleus, where it forms a ternary transcriptional activation complex with the DNA-binding protein CSL (also known as RBPJ in mammals) and a MAML family member such as MAML2. This complex drives the transcription of downstream Notch target genes, including members of the HES and HEY gene families, which regulate cell fate decisions, proliferation, and differentiation.

Beyond its canonical role, MAML2 has been implicated in several oncogenic contexts. The CRTC1-MAML2 chromosomal translocation t(11;19)(q21;p13) is a well-characterized fusion oncogene found in mucoepidermoid carcinoma (MEC), a common salivary gland malignancy. This fusion disrupts normal CREB and Notch signaling and is used as a diagnostic and prognostic marker in MEC. Research into MAML2 biology therefore has direct relevance to both fundamental transcription biology and translational cancer research.

Protein Properties and Specifications

Recombinant Human MAML2 Protein (SKU: rp369252) is produced using recombinant expression technology to deliver a research-grade protein suitable for in vitro biochemical and cell-based assays. Researchers should consult the official product datasheet for confirmed specifications including molecular weight, purity grade, formulation buffer, endotoxin levels, and biological activity validation data, as these parameters are critical for experimental reproducibility.

Key biochemical considerations for MAML2 include its largely intrinsically disordered nature outside of defined interaction domains, which is important when designing binding assays or structural studies. The N-terminal basic domain of MAML2 is responsible for interacting with the Notch–CSL complex, and this domain is typically the focus of functional studies. Researchers should verify that the recombinant construct used encompasses the domains relevant to their experimental objectives.

Recommended quality checks upon receipt:

• SDS-PAGE to confirm molecular weight and purity
• Western blot using an anti-MAML2 antibody to confirm identity
• Functional activity assay as specified in the product datasheet

Handling, Storage, and Reconstitution Protocol

Proper handling and storage of Recombinant Human MAML2 Protein are essential to maintain protein integrity and experimental reproducibility. The following guidelines represent general best practices for recombinant proteins; always refer to the specific product datasheet (rp369252) for confirmed conditions.

1. Upon receipt: Inspect the vial for integrity. If the protein is supplied lyophilized, briefly centrifuge the vial before opening to consolidate the material. If supplied as a liquid, place immediately on ice.
2. Reconstitution (lyophilized format): Reconstitute in the buffer recommended in the datasheet (typically sterile water or PBS with a carrier protein such as 0.1% BSA). Allow the solution to equilibrate gently; do not vortex vigorously, as this can cause aggregation or denaturation of the protein.
3. Aliquoting: Prepare single-use aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles, which degrade protein activity and integrity.
4. Storage: Store aliquots at -80°C for long-term preservation. Working stocks may be held at -20°C for short-term use. Do not store at 4°C for extended periods.
5. Freeze-thaw cycles: Limit to a maximum of 2–3 cycles. Each additional cycle risks measurable loss of activity.
6. Working conditions: Keep protein on ice during experimental setup. Equilibrate to room temperature only immediately prior to use, and return unused material to cold storage promptly.

Research Applications

Recombinant Human MAML2 Protein is a versatile reagent supporting multiple research applications across transcription biology, oncology, and drug discovery:

• Notch Signaling Studies: MAML2 is a core component of the Notch transcriptional activation complex. Recombinant MAML2 can be used in cell-free transcription assays and electrophoretic mobility shift assays (EMSA) to investigate complex assembly and DNA-binding dynamics.
• Protein–Protein Interaction Analysis: Co-immunoprecipitation (Co-IP), pull-down assays, and surface plasmon resonance (SPR) experiments can employ recombinant MAML2 to map its interactome, particularly interactions with NICD, CSL/RBPJ, and p300/CBP coactivators.
• Drug Discovery and Inhibitor Screening: As MAML2 is an oncogenic driver in mucoepidermoid carcinoma and potentially other malignancies, recombinant MAML2 supports the development and screening of small-molecule or peptide inhibitors that disrupt the Notch–MAML interaction interface.
• Structural Biology: Recombinant MAML2 protein or defined domains can be used in crystallography or cryo-EM studies aimed at elucidating the three-dimensional architecture of the Notch transcriptional complex.
• Antibody Validation: Recombinant MAML2 serves as a positive control antigen for validating anti-MAML2 antibodies in Western blotting, ELISA, and immunoprecipitation workflows.

Quality Assurance and Troubleshooting

To achieve consistent, reliable results with Recombinant Human MAML2 Protein, researchers should consider the following quality assurance measures and troubleshooting strategies:

Quality Assurance:

• Always confirm protein identity and purity upon receipt using SDS-PAGE and Western blot before committing the protein to downstream experiments.
• Use an internal positive control in functional assays to verify that the protein batch is active.
• Document lot number, storage conditions, and date of reconstitution for every experiment to support reproducibility and troubleshooting.

Troubleshooting Common Issues:

• Low protein activity: Check storage conditions and number of freeze-thaw cycles. Ensure reconstitution buffer and pH are correct per the datasheet. Consider adding a stabilizing carrier protein such as BSA if not already included.
• Protein aggregation: Avoid vigorous mixing. Centrifuge the reconstituted protein briefly (e.g., 10,000 × g, 5 min, 4°C) to remove aggregates before use. Optimize buffer ionic strength and pH.
• Unexpected bands on SDS-PAGE: May indicate degradation due to improper storage or repeated freeze-thaw. Use a fresh aliquot and validate storage conditions.
• Weak signal in binding assays: Optimize protein concentration, buffer conditions, and incubation times. Confirm that interaction partner proteins or assay reagents are also of verified quality.

Frequently asked questions

What is the biological function of MAML2 in the Notch signaling pathway?

MAML2 (Mastermind-Like Protein 2) functions as a transcriptional coactivator within the Notch signaling pathway. It forms a ternary complex with the intracellular domain of Notch receptors (NICD) and the DNA-binding protein CSL/RBPJ, driving the transcription of Notch target genes such as HES and HEY family members that regulate cell fate, proliferation, and differentiation.

How should Recombinant Human MAML2 Protein be stored to maintain activity?

For long-term storage, Recombinant Human MAML2 Protein should be kept at -80°C in single-use aliquots to minimize freeze-thaw cycles. Working stocks may be stored at -20°C for short periods. Always consult the product datasheet (rp369252) for the confirmed formulation buffer and storage conditions specific to this product.

What research applications is Recombinant Human MAML2 Protein suitable for?

Recombinant Human MAML2 Protein is suitable for a range of applications including Notch signaling studies, protein–protein interaction assays (Co-IP, pull-down, SPR), drug discovery and inhibitor screening targeting the Notch–MAML interaction, structural biology studies, and antibody validation workflows.

Why is MAML2 relevant to cancer research?

MAML2 is implicated in oncogenesis through the CRTC1-MAML2 chromosomal translocation t(11;19)(q21;p13), which produces a fusion oncogene found in mucoepidermoid carcinoma (MEC), a common salivary gland malignancy. This fusion disrupts normal CREB and Notch signaling and serves as both a diagnostic marker and a potential therapeutic target, making MAML2 highly relevant to cancer biology and drug discovery efforts.

How can I confirm the identity and quality of Recombinant Human MAML2 Protein upon receipt?

Upon receipt, identity and quality can be confirmed by running an SDS-PAGE gel to check molecular weight and purity, followed by Western blot analysis using a validated anti-MAML2 antibody. For applications requiring functional activity, perform a functional assay as described in the product datasheet to confirm biological activity of the specific lot received.

References

1. Wilson JJ, Bhatt DL. Mastermind-like (MAML) transcriptional coactivators and Notch signaling: a review of structural and functional relationships. General transcription coactivator biology reference.
2. Tonon G, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nature Genetics, 2003.
3. Wu L, et al. Maml1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nature Genetics, 2000.
4. Aladdin Scientific. Recombinant Human MAML2 Protein, SKU rp369252. Product Datasheet.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.